Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moderna Inc
(NQ:
MRNA
)
117.31
-5.38 (-4.39%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Moderna Inc
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
99
100
Next >
'I Think It's Peaked Already': Jim Cramer On This Stock Up 22% Over Past Month
February 10, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Okta Inc (NASDAQ: OKTA) CEO Todd McKinnon has "got to pivot first.
Via
Benzinga
Is Novavax Stock a Buy With the New Normal for COVID?
February 10, 2023
The landscape has shifted dramatically in the COVID-19 vaccine market.
Via
The Motley Fool
Is Biotech Immunocore About To Make A 25% Price Move?
February 07, 2023
Small-cap Immunocore has been a price leader within the biotech industry. Analysts have a "buy" rating on the stock and estimate that it will move 25% higher.
Via
MarketBeat
Topics
ETFs
Analyst Upgrades Personalis; Says Biopharma Is Strong, Cash Burn Is Down
February 06, 2023
Via
Benzinga
1 Company Bucks the Office REIT Trend With Higher Rents and Earnings
February 06, 2023
Life sciences companies may be more immune to work-from-home shifts.
Via
The Motley Fool
Is Moderna Stock a Buy Now?
February 03, 2023
The company is starting the year on a strong note.
Via
The Motley Fool
Could This RSV News Make Moderna a Hot Buy Again?
January 25, 2023
The company could soon have a new vaccine bringing in revenue.
Via
The Motley Fool
Danaher Shows Interest In Acquiring Catalent Valued At Significant Premium: Report
February 06, 2023
Danaher Corporation (NYSE: DHR) has reportedly expressed interest in acquiring the contract manufacturer Catalent Inc (NYSE: CTLT).
Via
Benzinga
EXCLUSIVE: Top 10 Most Searched Tickers On Benzinga Pro In January: Where Do SPY, Tesla, Apple And Ford Rank?
February 05, 2023
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers.
Via
Benzinga
3 No-Brainer Growth Stocks to Buy in 2023
February 03, 2023
These stocks all fell by double digits last year.
Via
The Motley Fool
Why Personalis Shares Are Trading Higher Today
February 03, 2023
Via
Benzinga
Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials
February 03, 2023
From
Personalis, Inc.
Via
Business Wire
The 7 Most Undervalued Biotech Stocks to Buy in February 2023
February 02, 2023
Get your hands on the latest medical innovations at a compelling discount with the most undervalued biotech stocks to buy.
Via
InvestorPlace
Moderna to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 23, 2023
February 02, 2023
Via
ACCESSWIRE
The 7 Most Undervalued Nasdaq Stocks to Buy in February 2023
February 01, 2023
For those seeking the best discounts in the tech-centered index, these are the most undervalued Nasdaq stocks to buy.
Via
InvestorPlace
Novavax Shares Jumped in January While Others Slipped
February 01, 2023
Updated FDA Covid vaccine policy could've boosted NVAX shares at the end of January, when other pharma stocks slipped, but it may not affect the bottom line.
Via
MarketBeat
Exposures
COVID-19
Product Safety
1 Reason to Buy Novavax in 2023 and 2 Reasons to Sell
February 01, 2023
Novavax shares sank 93% last year.
Via
The Motley Fool
This Discount Growth Stock Is a Once-in-a-Decade Buying Opportunity Right Now
January 31, 2023
Moderna stock has dropped 60% from its peak.
Via
The Motley Fool
Why BioNTech And Moderna Shares Are Falling After Pfizer News
January 31, 2023
BioNTech SE - ADR (NASDAQ: BNTX) and Moderna Inc (NASDAQ: MRNA) shares are trading lower Tuesday morning in sympathy with Pfizer Inc. (NYSE:
Via
Benzinga
Biden Administration Plans To End COVID-19 Public Health Emergency In May
January 31, 2023
Via
Benzinga
$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns
January 30, 2023
The COVID-19 pandemic emerged in 2019 in China and spread to the rest of the globe in early 2020. Since then, the virus has caused more than 6.8 million deaths.
Via
Benzinga
The RSV Vaccine Battle Wages On With Moderna Scoring A Win Vs. Pfizer, GSK
January 30, 2023
But Moderna stock didn't move higher on the announcement.
Via
Investor's Business Daily
Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus (RSV) Vaccine Candidate
January 30, 2023
Via
ACCESSWIRE
2 Struggling Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague
January 29, 2023
Two of these stocks have what it takes to rebound and deliver lasting gains.
Via
The Motley Fool
Novavax Jumps After Pledging To Update Its Covid Shot; Pfizer, Moderna Slip
January 27, 2023
The FDA's experts voted in favor of annual boosters on Thursday.
Via
Investor's Business Daily
The 3 Best Biotech Stocks Under $1 to Buy for January
January 26, 2023
Even the best small biotech stocks can go bust on a single bad study, but the winners can make their early investors rich.
Via
InvestorPlace
2 Top Biotech Stocks to Buy for the Long Haul
January 26, 2023
Developing new products will be key to the success of both of these biotech leaders.
Via
The Motley Fool
Mergers and Acquisitions in 2023 Off To A Strong Start
January 26, 2023
Mergers and acquisitions are common, especially across the health sector. Here are some lesser-known buyouts and how they could fare down the road.
Via
MarketBeat
Exposures
Product Safety
How Could GSK's RSV Vaccine Change its Valuation?
January 26, 2023
GSK's RSV vaccine could be a good earner for the company, according to outside analysts and its own predictions for the future.
Via
MarketBeat
Exposures
Product Safety
Thursday Predictions: 3 Hot Stocks for Tomorrow
January 25, 2023
Airline stocks, credit card stocks, and vaccine stocks are our focus when it comes to the hot stocks for tomorrow. Here's why.
Via
InvestorPlace
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.